ARTICLE | Company News
Aposense, University of Pittsburgh deal
April 11, 2011 7:00 AM UTC
The university received a license to use Aposense's EarliTest imaging technology in a NIH-funded clinical trial to treat glioblastoma multiforme (GBM). The university has the right to publish the data...